Candidiasis, Oral Clinical Trial
Official title:
Evaluation of the Effect of Different Cleaning and Disinfection Procedures on the Involvement of Candida Species
Individuals may experience tooth loss as a result of trauma, periodontal destruction, lack of
adequate bone support and clinically dental mobility. The increase in these tooth loss
results in a condition called complete toothlessness in patients, and as a result of this,
dentists treat complete dentures. It is known that the microorganism retention in the
existing restorations is faster and higher than the natural tissues, and this leads to faster
plaque build-up and hence bad odor. Candida species are common in oral flora, because they
are numerous in the mouth and they are opportunistic pathogenic fungi that can make
superficial and deep infections. The most important pathogen species among these parasites is
Candida albicans. Mouth moniliasis or acute pseudomembrane candidiasis in the oral cavity of
the so-called canker is caused by C.albicans. Chronic hyperplastic candidiasis is a clinical
entity that is clinically inseparable from leukoplakia and completely separate from thrush.
The accumulation of microorganisms in prosthetic materials is very important for the
protection of the health of oral tissues and it is desirable to use appropriate cleaning and
disinfection materials to minimize this accumulation.
It is known in the literature that ozone and microwave technologies are used as disinfection
technique. In this study, the application of ozone and microwave technologies in addition to
the cleaning agents used as standard treatment will be compared in vivo. No such research has
been found.The aim of this study was to evaluate the effect of different cleaning and
disinfection procedures on the involvement of Candida species in complete denture patients.
The study is planned to be performed on 72 patients between the ages of 18-70 who were
diagnosed and followed up in the Department of Prosthodontics of the Faculty of Dentistry of
Yuzuncu Yil University. Patients with complete disability and indication of total prosthesis
are included in the case group. In addition, individuals with systemic disturbance of
salivation, radiotherapy-chemotherapy patients who are known to be able to facilitate Candida
growth will be excluded from our study. The complete prosthesis made of
polymethylmethacrylate material will be delivered to the patients. Before delivery, the
polished surfaces of the relevant prosthesis, its vertical size, whether the patient is
suitable for use or not, and the delivery of the prostheses that have passed the relevant
controls will be considered appropriate. Patients will be asked to come for follow-up at 1
week and 1 month after the delivery of full dentures. The patients will be delivered with one
of the glutaraldehyde, sodium hypochlorite or chlorhexidine digluconate solutions as the
cleaning solution determined by the researchers during the initial delivery of their
prostheses. Patients will be asked to clean with this relevant solution twice a day, in
accordance with the specified times. At the 1 st and 1 st month follow-up, the prosthesis
will be taken for the determination of the Candida number and species and the following
procedures will be applied. Delivered prostheses will be taken in a 250 ml beaker (containing
100 ml of distilled water). Then, with the help of a swab, it will be contacted to the inner
surfaces and edges of the prosthesis to allow mixing into the distilled water in possible
biofilm layers.
Then, the prosthesis will be removed and the distilled water will be homogenized by mixing
thoroughly with the help of a stirrer. Later Zhou et al. According to the method used; 1 ml
of distilled water will be transferred to falcon tubes. Pre-cultural Falcon tubes will be
kept on ice for up to 1 hour.
Prior to culture, samples will be diluted with sterile distilled water (1: 1, 1:10, 1: 100).
And be mixed well using a vortex mixer. Then take 0.5 ml of these diluted liquids to be
planted in Sabouraud Dextrose Agar. After 48 hours of incubation (microscopic and macroscopic
evaluation), the number of colony forming units (CFU) of distilled water will be counted
using two researchers. Then, Candida lara will be identified by an API test which will
include 19 carbohydrate assimilation tests and negative control.
The same processes will be repeated after the disinfection process with ozone or microwave to
compare the effectiveness of the disinfection process. Thus, the daily recommended by
physicians for the daily cleaning process, the suppression of reproduction and reproduction
of Candida species, and a new method proposed by physicians to be applied as a new method of
ozone and microwave and how much efficiency of sterilization on the Candida number will be
compared on the basis of the effects will be compared.
Statistical analysis will be done and interpreted.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03250923 -
CelAgaceā¢ OraRinse Solution for Treatment of Candidiasis
|
Phase 1/Phase 2 | |
Completed |
NCT00004781 -
Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups
|
N/A | |
Completed |
NCT00128323 -
A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis
|
Phase 3 | |
Recruiting |
NCT04410250 -
Effect of Oral Hygienization in Newborn on Candida Spp Colonization
|
N/A | |
Completed |
NCT02184351 -
Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis
|
Phase 3 | |
Recruiting |
NCT03873753 -
Relationship Between Oral Hygiene in Newborns and Candida Spp.
|
N/A | |
Completed |
NCT00665639 -
Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis
|
Phase 3 | |
Completed |
NCT02818803 -
Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic
|
Phase 3 | |
Active, not recruiting |
NCT06120816 -
Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis
|
Phase 1 | |
Completed |
NCT00235053 -
Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID
|
Phase 4 | |
Completed |
NCT00666185 -
Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis
|
Phase 3 | |
Completed |
NCT00002446 -
Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients
|
Phase 3 | |
Completed |
NCT00001448 -
The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection
|
N/A | |
Completed |
NCT00612963 -
Novel Rinse to Treat in Oral Candidiasis in Cancer Patients
|
N/A | |
Completed |
NCT00001812 -
A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2
|
Phase 3 | |
Completed |
NCT00000951 -
A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush
|
Phase 4 | |
Completed |
NCT00002399 -
A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients
|
Phase 2 | |
Completed |
NCT00002431 -
The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients
|
N/A | |
Terminated |
NCT00005920 -
Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole
|
Phase 2 | |
Completed |
NCT00002341 -
A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole
|
N/A |